Sign in

CIK 0001446847 · Accelerated filer<br>Smaller reporting company

IRONWOOD PHARMACEUTICALS INC

Sign in to watch
Ticker
IRWD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
043404176
Phone
617-621-7722
Business address
100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
  1. 4 Open-market sale Chief Executive Officer sold 19,959 shares at $11.58 ($231,125)
  2. 4 Grant or award Director acquired 1,222 shares (grant or award)
  3. 4 Open-market sale Director sold 7,610 shares at $11.65 ($88,657)
  4. 4 Open-market sale Director sold 190,383 shares at $12.01 ($2,286,500)
  5. 3 Insider Initial Statement of Ownership
  6. 4 Grant or award Director acquired 21,571 shares (grant or award)
  7. 4 Grant or award Director acquired 21,571 shares (grant or award)
  8. 4 Grant or award Director acquired 21,571 shares (grant or award)
  9. 4 Grant or award Director acquired 21,571 shares (grant or award)
  10. 4 Grant or award Director acquired 21,571 shares (grant or award)
  11. 4 Grant or award Director acquired 21,571 shares (grant or award)
  12. 4 Grant or award Director acquired 21,571 shares (grant or award)
  13. 4 Grant or award Director acquired 21,571 shares (grant or award)
  14. 4 Open-market sale Chief Executive Officer sold 36,308 shares at $11.50 ($417,542)
  15. 4 Open-market sale Principal Accounting Officer sold 120 shares at $11.50 ($1,380)
  16. 4 Open-market sale CMO,SVP,Head-Res&Drug sold 10,583 shares at $11.50 ($121,705)
  17. 4 Open-market sale SVP, Chief Operating Officer sold 13,537 shares at $11.50 ($155,676)
  18. 4 Open-market sale Principal Accounting Officer sold 3,031 shares at $12.75 ($38,645)
  19. 4 Grant or award Director acquired 1,152 shares (grant or award)
  20. 4 Grant or award Director acquired 1,466 shares (grant or award)

Page 9 of 41 · 806 filings